Unknown

Dataset Information

Commercial Price Variation for Breast Reconstruction in the Era of Price Transparency.


ABSTRACT:

Importance

Breast reconstruction is costly, and negotiated commercial rates have been hidden from public view. The Hospital Price Transparency Rule was enacted in 2021 to facilitate market competition and lower health care costs. Breast reconstruction pricing should be analyzed to evaluate for market effectiveness and opportunities to lower the cost of health care.

Objective

To evaluate the extent of commercial price variation for breast reconstruction. The secondary objective was to characterize the price of breast reconstruction in relation to market concentration and payer mix.

Design, setting, and participants

This was a cross-sectional study conducted from January to April 2022 using 2021 pricing data made available after the Hospital Price Transparency Rule. Nat

SUBMITTER: Rochlin DH 

PROVIDER: S-EPMC9856784 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature